About 5 results found for searched term "56-34-8" (0.069 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1700 | Momelotinib (CYT387) | JAK |
| LM-1149; Momelotinib; CYT 11387 | ||
| Momelotinib (CYT387) is a small-molecule, ATP-competitive JAK1/JAK2 inhibitor with IC50 of 11 and 18 nM respectively. | ||
| M7156 | PPY A | Others |
| PPY A is a potent inhibitor of Abl T315l mutant and wild-type Abl kinases. | ||
| M10624 | Tetraethylammonium chloride | Potassium Channel |
| TEACl | ||
| Tetraethylammonium chloride is a non-selective potassium channel blocker with antitumor properties. | ||
| M10945 | Chiauranib | VEGFR/PDGFR |
| CS2164 | ||
| Chiauranib (CS2164) is a first-in-class orally active multi-target inhibitor of tumor angiogenesis.Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRα and c-Kit), mitosis-related kinase Aurora B and chronic inflammation-related kinase CSF-1R. Chiauranib has strong anticancer activity. | ||
| M40721 | Mabuterol | Adrenergic Receptor |
| Mabuterol is a selective, orally active beta-2 adrenergic receptor (β2-AR) agonist. Mabuterol inhibits PDGF-BB-induced cell proliferation, increased intracellular Ca2+, and Drp-1, cyclinD1, and PCNA protein expression, and enhances Mfn-2 expression. Can be used in studies of airway obstruction and chronic obstructive pulmonary disease (COPD). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
